The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Abstract
The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia. Striatal projection neurons target the substantia nigra pars reticulata (direct pathway) or the lateral globus pallidus (indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease. However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity. Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-d-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which may give rise to an aberrant learning that further impairs automatic motor behavior 45, 46.”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [46]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,655
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
Cited by
Sorted by citations
Items 501–600 of 732
Cannabinoids in Parkinson’s disease
Concannon, R. M., Finn, D. P., & Dowd, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00003-5 · Cited by 11
Endocannabinoids at the Synapse: Retrograde Signaling and Presynaptic Plasticity in the Brain
Gerdeman, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_11 · Cited by 11
Current Understanding of PDE10A in the Modulation of Basal Ganglia Circuitry
Schülke, J.-P., & Brandon, N. J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_2 · Cited by 11
Morató, X., Gonçalves, F. Q., Lopes, J. P., Jáuregui, O., Soler, C., Fernández‐Dueñas, V., Cunha, R. A., & Ciruela, F. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14653 · Cited by 11
Axonal degeneration in Parkinson's disease – Basal ganglia circuitry and D2 receptor availability
Pelzer, E. A., Melzer, C., Schönberger, A. R., Hess, M., Timmermann, L., Eggers, C., & Tittgemeyer, M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101906 · Cited by 11
Organization of Corticostriatal Projection Neuron Types
Reiner, A. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00018-4 · Cited by 11
mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity
Wu, C., Jew, C. P., Sun, H., Ballester‐Rosado, C. J., & Lu, H. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05367-0 · Cited by 11
Future Perspectives of NMDAR in CNS Disorders
Capó, T., Rebassa, J. B., Raïch, I., Lillo, J., Badia, P., Navarro, G., & Reyes‐Resina, I. (2025) · Molecules · doi:10.3390/molecules30040877 · Cited by 12
From avoidance to new action: the multifaceted role of the striatal indirect pathway
Lee, J., & Sabatini, B. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00925-2 · Cited by 10
Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis
Urbi, B., Lee, Y., Hughes, I. P., Thorning, S., Broadley, S., Sabet, A., & Heshmat, S. (2022) · BMJ Open Science · doi:10.1136/bmjos-2022-100302 · Cited by 10
Daigle, T. L., Wetsel, W. C., & Caron, M. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07874.x · Cited by 10
Nahir, B., Lindsly, C., & Frazier, C. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.022 · Cited by 10
Ingebretson, A. E., Hearing, M. C., Huffington, E. D., & Thomas, M. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.011 · Cited by 10
The Endocannabinoid System is a Major Player in Schizophrenia
Köfalvi, A., & Fritzsche, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_22 · Cited by 10
Báldi, R., Ghosh, D., Grueter, B. A., & Patel, S. (2016) · Current Protocols in Neuroscience · doi:10.1002/cpns.8 · Cited by 10
GABA and Glutamate Synaptic Coadaptations to Chronic Ethanol in the Striatum
Carlson, V. C. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_98 · Cited by 10
Komeili, G., Haghparast, E., & Sheibani, V. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113342 · Cited by 10
Zhai, S., Cui, Q., Wokosin, D. L., Sun, L., Tkatch, T., Crittenden, J. R., Graybiel, A. M., & Surmeier, D. J. (2025) · Science Advances · doi:10.1126/sciadv.adv8224 · Cited by 11
Liu, W., Li, L., Kuang, H., Xia, Y., Wang, Z., Liu, S., & Yin, D. (2018) · BioMed Research International · doi:10.1155/2018/2828143 · Cited by 9
Castela, I., & Hernández, L. F. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14777 · Cited by 10
Thabault, M., Turpin, V., Balado, É., Fernandes‐Gomes, C., Huot, A.-L., Cantereau, A., Fernagut, P., Jaber, M., & Galvan, L. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15919 · Cited by 9
Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations
Belić, J. J., Kumar, A., & Kotaleski, J. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175135 · Cited by 9
Physiological aging at striatal synapses
Walsh, J. P., & Akopian, G. K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24484 · Cited by 9
Li, W., & Pozzo‐Miller, L. D. (2019) · eNeuro · doi:10.1523/eneuro.0118-19.2019 · Cited by 9
Ruggiero, R. N., Bueno-Júnior, L. S., Ross, J. B. D., Fachim, H., Padovan‐Neto, F. E., Merlo, S., Rohner, C. J. S., Ikeda, E. T., Brusco, J., & Moreira, J. E. (2011) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v44i2p143-156 · Cited by 9
Astrocytes tell neurons when to listen up
Gittis, A. H., & Brasier, D. J. (2015) · Science · doi:10.1126/science.aad0678 · Cited by 11
He, Q., Zhang, X., Yang, H., Wang, D., Shu, Y., & Wang, X. (2024) · iScience · doi:10.1016/j.isci.2024.111253 · Cited by 8
Zhang, L., Zhou, Y., Liu, C., Zheng, W., Yao, Z., Wang, Q., Jin, Y., Zhang, S., Chen, W., & Chen, J. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108250 · Cited by 8
Zhang, L., Zeng, Z.-H., Lu, X.-Y., Li, M., Yao, J., Zou, G.-J., Chen, Z., Li, Q., Li, C.-Q., & Li, F. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00640-9 · Cited by 8
Lee, H., Kim, H. F., & Hikosaka, O. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105719 · Cited by 8
Lim, S. A. O., & Surmeier, D. J. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.626412 · Cited by 8
Cannabinoids for the Treatment of Movement Disorders
Catlow, B. J., & Sanchez‐Ramos, J. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0370-5 · Cited by 8
The ins and outs of endocannabinoid signaling in healthy and diseased brain
Horne, E. A., & Stella, N. (2008) · Future Lipidology · doi:10.2217/17460875.3.4.435 · Cited by 8
Rosas‐Arellano, A., Estrada‐Mondragón, A., Mantellero, C. A., Tejeda-Guzmán, C., & Castro, M. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230270 · Cited by 8
Shi, Z., Wen, K., Sammudin, N. H., LoRocco, N. C., & Zhuang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03013-0 · Cited by 7
Calabrese, V., Picconi, B., Heck, N., Campanelli, F., Natale, G., Marino, G., Sciaccaluga, M., Ghiglieri, V., Tozzi, A., Anceaume, E., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109205 · Cited by 8
Soti, M., Ranjbar, H., Kohlmeier, K. A., Razavinasab, M., Masoumi‐Ardakani, Y., & Shabani, M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.015 · Cited by 7
Retinoic Acid Signaling: A New Piece in the Spoken Language Puzzle
van Rhijn, J.-R., & Vernes, S. C. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01816 · Cited by 7
Lee, Y., Han, N.-E., Kim, W., Kim, J. G., Lee, I. B., Choi, S. J., Chun, H., Seo, M., Lee, C. J., Koh, H.-Y., et al. (2020) · PubMed Central · doi:10.14348/molcells.2019.0279 · Cited by 7
Burguière, A., Bundel, D. D., Valjent, E., Roger, J., Smolders, I. J., Fagni, L., & Perroy, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.017 · Cited by 7
Cannella, M., Motolese, M., Bucci, D., Molinaro, G., Gradini, R., Bruno, V., Nicoletti, F., & Battaglia, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.024 · Cited by 7
Zikereya, T., Liu, C., Wei, L., Wang, Y., Zhang, Z., Han, C., Shi, K., & Chen, W. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115289 · Cited by 6
Alpha-synuclein and RNA viruses: Exploring the neuronal nexus
Gupta, A., Bohara, V. S., Banasavadi‐Siddegowda, Y., Chaudhary, N., & Kumar, S. (2024) · Virology · doi:10.1016/j.virol.2024.110141 · Cited by 6
Sound-Evoked Responses of Distinct Neuron Classes from the Tail of the Striatum
Nardoci, M. B., Lakunina, A. A., Henderling, D. C., Pedregon, J. C., Mohn, J. L., & Jaramillo, S. (2022) · eNeuro · doi:10.1523/eneuro.0201-22.2022 · Cited by 6
Effects of heterozygous deletion of autism-related gene Cullin-3 in mice
Xia, Q., Walker, A. K., Song, C., Wang, J., Singh, A., Mobley, J. A., Xuan, Z., Singer, J. D., & Powell, C. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283299 · Cited by 6
Augustin, S. M., Gracias, A. L., Luo, G., Anumola, R. C., & Lovinger, D. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01671-8 · Cited by 6
The Corticostriatal Pathway in Parkinson’s Disease
Bamford, N. S., & Cepeda, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_6 · Cited by 6
Apomorphine‐induced modulation of neural activities in the ventrolateral striatum of rats
Fujita, S., Kato, R., Cui, Y., Terakado, M., Suga, K., Koshikawa, N., & Kobayashi, M. (2013) · Synapse · doi:10.1002/syn.21644 · Cited by 6
Introductory Chapter: Mechanisms and Function of Synaptic Plasticity
Heinbockel, T. (2017) · InTech eBooks · doi:10.5772/67891 · Cited by 6
D1 and D2 Dopamine Receptor Modulation of Glutamatergic Signaling in Striatal Medium Spiny Neurons
Surmeier, D. J., Day, M., Gertler, T. S., Chan, C. S., & Shen, W. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00006-8 · Cited by 6
Alterations in Corticostriatal Synaptic Function in Huntington's and Parkinson's Diseases
Cepeda, C., Bamford, N. S., André, V. M., & Levine, M. S. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00035-4 · Cited by 6
Aberrant plasticity and "learned" motor inhibition in Parkinson's disease.
Zhuang, X. (2012) · PubMed · Cited by 6
Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
Shi, Z., Bamford, I. J., McKinley, J. W., Devi, S. P. S., Vahedipour, A., & Bamford, N. S. (2020) · Brain Sciences · doi:10.3390/brainsci10120903 · Cited by 6
Cannabinoid type 1 receptors in A2a neurons contribute to cocaine-environment association
Turner, B. D., Smith, N. K., Manz, K. M., Chang, B. T., Delpire, E. J., Grueter, C. A., & Grueter, B. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05759-1 · Cited by 6
Parra, H. R., Misgeld, U., & Yanovsky, Y. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.062 · Cited by 6
ElShebiney, S. A. (2014) · Cell Biology Research & Therapy · doi:10.4172/2324-9293.1000112 · Cited by 5
The Bac Transgenic Approach to Study Parkinson's Disease in Mice
Yang, X. W., & Lu, X. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00019-1 · Cited by 5
Deep-Brain Stimulation for Neurologic and Psychiatric Disorders
Wichmann, T., & DeLong, M. R. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00039-1 · Cited by 5
Plenz, D., & Wickens, J. R. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00005-6 · Cited by 5
The Endocannabinoid System and Human Brain Functions
Ashton, J. C., Dowie, M. J., & Glass, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00005-8 · Cited by 7
He, Y., Xu, B., Chen, Y., Xu, L., Xu, L., Chen, Y., & Long, D. (2021) · Brain Structure and Function · doi:10.1007/s00429-020-02183-7 · Cited by 6
Collagen VI Regulates Motor Circuit Plasticity and Motor Performance by Cannabinoid Modulation
Lam, D. D., Williams, R. H., Lujan, E., Tanabe, K., Huber, G., Saw, N. L., Merl‐Pham, J., Salminen, A. V., Lohse, D., Spendiff, S., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0962-21.2021 · Cited by 5
Lepora, N. F., Blomeley, C. P., Hoyland, D., Bracci, E., Overton, P. G., & GURNEY, K. N. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07879.x · Cited by 5
A journey through cannabidiol in Parkinson’s disease
Del-Bel, E., Barros, N., de Moraes, R. A. P. D. S., de Mattos, B. A., Alves-Fernandes, T. A., de Abreu, L. B., Nascimento, G. C., Escobar-Espinal, D. M., Pedrazzi, J. F. C., Jacob, G. A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.015 · Cited by 4
Endocannabinoid signaling in epilepsy
Zeng, C., & Chen, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107074 · Cited by 4
Uzay, B., Zhang, K. J., Monteggia, L. M., & Kavalali, E. T. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03374-6 · Cited by 4
Kong, J., Yang, Z., Wang, Y., Liu, L., Liu, Y., & Chen, W. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01551-z · Cited by 4
Involvement of the Endocannabinoid System in Ethanol-Induced Corticostriatal Synaptic Depression
Cho, H. S., Jeun, S. H., Li, Q., Kim, K., Choi, S. J., & Sung, K.-W. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12118fp · Cited by 4
Bridging the Gap: Muscarinic M4 Receptors Promote Striatal Plasticity in Health and Disease
Girasole, A. E., & Nelson, A. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.007 · Cited by 4
Receptors and Second Messengers in the Basal Ganglia
Warren, E. B., Sillivan, S. E., & Konradi, C. L. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00028-3 · Cited by 6
Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson’s Disease
Du, Y., & Graves, S. M. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00017 · Cited by 4
Regenerative Medicine of Neural Tissues
Stocum, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384860-4.00011-3 · Cited by 4
Adaptive Gene Regulation in the Striatum of RGS9-Deficient Mice
Busse, K., Strotmann, R., Strecker, K., Wegner, F., Devanathan, V., Gohla, A., Schöneberg, T., & Schwarz, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092605 · Cited by 5
PQBP1: A New Player in Metabotropic Glutamate Receptor Signaling and Synaptic Plasticity
Su, L., & Shen, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00720-w · Cited by 4
Connectivity and Excitability Shape Seizure Circuits
Brodovskaya, A., & Kapur, J. (2022) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597221136961 · Cited by 4
Distinctive physiology of molecularly identified medium spiny neurons in the macaque putamen
Ting, J. T., Johansen, N., Kalmbach, B. E., Taskin, N., Lee, B., Clark, J. K., Kendrick, R. M., Ng, L., Radaelli, C., Weed, N., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114963 · Cited by 6
Endocannabinoids and Dopamine Balance Basal Ganglia Output
Gorodetski, L., Loewenstern, Y., Faynveitz, A., Bar‐Gad, I., Blackwell, K. T., & Korngreen, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.639082 · Cited by 3
Vukadinovic, Z. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.11.014 · Cited by 3
Phasic Dopaminergic Signaling: Implications for Parkinson’s Disease
Sandberg, S. G., & Phillips, P. E. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_3 · Cited by 3
Kurose, S., Kubota, M., Takahata, K., Yamamoto, Y., Fujiwara, H., Kimura, Y., Ito, H., Takeuchi, H., Mimura, M., Suhara, T., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25538 · Cited by 3
Wu, Y., Yi, X., Gu, X. F., Wang, Q., Jiang, Q., Li, Y., Zhu, M. X., Ding, J., Li, W., & Xu, T. (2023) · iScience · doi:10.1016/j.isci.2023.106322 · Cited by 3
Alçığır, M. E., Doğan, H. O., Vural, S. A., & Yılmaz, F. M. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22516 · Cited by 3
Cannabinoids in the Treatment of Parkinson’s Disease
Gandor, F., & Ebersbach, G. (2017) · Neurology International Open · doi:10.1055/s-0043-115359 · Cited by 3
Regional heterogeneity in the membrane properties of mouse striatal neurons
Chuhma, N., & Rayport, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1412897 · Cited by 2
Estrada-Valencia, R., Túnez, I., Tinkov, A. A., Aschner, M., López, T., Pedraza‐Chaverrí, J., & Santamarı́a, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05104-z · Cited by 2
Xu, Y., Zhang, S., Mi, J., Lu, X., An, Y., Liu, J., Sun, J., Wang, Y., & Xu, G. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01333-8 · Cited by 2
Synaptic Triad in the Neostriatum
Klug, J. R., Deutch, A. Y., Colbran, R. J., & Winder, D. J. (2011) · Frontiers in neuroscience · doi:10.1201/b11284-5 · Cited by 2
Functional foods and Parkinson's disease: A focus on omega-3 fatty acids
Li, P., & Song, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91747-6.00007-x · Cited by 2
Shan, Q., Yu, X., Lin, X., & Tian, Y. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106582 · Cited by 2
Paget-Blanc, V., Cavaccini, A., Longaretti, A., Nava, L., Trusel, M., Rocchi, A., Pennuto, M., Marcello, E. E., Gardoni, F., Greco, B., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003288 · Cited by 2
Facing the Unique Challenges of Dyskinesias In Parkinson‘s Disease
Homayoun, H., & Goetz, C. G. (2012) · Future Neurology · doi:10.2217/fnl.12.4 · Cited by 2
A Molecular Switch for Induction of Long-Term Depression of Corticostriatal Transmission: Figure 1.
Kheirbek, M. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2938-07.2007 · Cited by 2
Dopamine–Endocannabinoid Interactions in Parkinson’s Disease
McCallum, S. E., & Cheer, J. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_12 · Cited by 2
Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors
Abood, M. E., Sorensen, R. G., & Stella, N. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_12 · Cited by 2
del Pilar, E. (2012) · Cited by 2
Brain Imaging of Cannabinoid Receptors
Casteels, C., Bormans, G. M., & Laere, K. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00003-8 · Cited by 2
Dopaminergic Modulation of Glutamatergic Signaling in Striatal Spiny Projection Neurons
Shen, W., Plokin, J. L., Zhai, S., & Surmeier, D. J. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00009-x · Cited by 2
Endocannabinoid-Dependent Synaptic Plasticity in the Striatum
Atwood, B. K., & Lovinger, D. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_5 · Cited by 2
Regenerative Medicine of Neural Tissues
Stocum, D. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012369371-6/50023-x · Cited by 2
Dopaminergic Modulation of Glutamatergic Signaling in Striatal Medium Spiny Neurons
Shen, W., & Surmeier, D. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_7 · Cited by 2
Metadata
- Authors
- Kreitzer, A. C., & Malenka, R. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Malenka, Robert C.
- Venue
- Nature
- Published
- 2007-02
- Volume
- 445
- Issue
- 7128
- Pages
- 643-647
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003314029
- Cited by
- 735
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 17 · 2021: 34 · 2020: 28 · 2019: 41 · 2018: 41 · 2017: 45 · 2016: 37 · 2015: 34 · 2014: 37 · 2013: 31 · 2012: 47
- FWCI
- 44.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- striatum, indirect pathway, direct pathway, medium spiny neurons, dopamine D2 receptor, basal ganglia, motor impairment, synaptic plasticity, NMDA receptor currents, release probability, transgenic mouse model, therapeutic target, Huntington's disease, substantia nigra pars reticulata
- MeSH terms
- Animals, Benzamides, Carbamates, Disease Models, Animal, Dopamine, Mice, Transgenic, Morpholines, Naphthalenes, Neuronal Plasticity, Parkinson Disease, Piperidines, Psychomotor Performance, Pyrazoles, Reserpine, Synapses, Receptors, N-Methyl-D-Aspartate, Oxidopamine, Neostriatum, Receptors, Dopamine D2, Excitatory Postsynaptic Potentials, Long-Term Synaptic Depression, Receptor, Cannabinoid, CB1, Benzoxazines, Mice, Cannabinoid Receptor Modulators, Endocannabinoids, Dopamine D2 Receptor Antagonists, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review